Ainos (AIMD) Stock Price, News & Analysis

Company Overview

Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.

Key Stats

• Today's Range: $0.48 to $0.55
• 50-Day Range: $0.47 to $0.68
• 52-Week Range: $0.45 to $4.29
• Volume: 172,685 shs
• Average Volume: 1.00 million shs
• Market Capitalization: $3.28 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AIMD Stock Analysis - Frequently Asked Questions

How have AIMD shares performed this year?

Ainos' stock was trading at $2.05 at the beginning of the year. Since then, AIMD stock has decreased by 75.4% and is now trading at $0.5048.
View the best growth stocks for 2024 here.

How were Ainos' earnings last quarter?

Ainos, Inc. (OTCMKTS:AIMD) announced its quarterly earnings results on Monday, August, 5th. The company reported ($0.49) earnings per share for the quarter. Ainos had a negative trailing twelve-month return on equity of 44.32% and a negative net margin of 515.80%.

When did Ainos' stock split?

Ainos's stock reverse split on the morning of Tuesday, August 9th 2022. The 1-15 reverse split was announced on Tuesday, August 9th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, August 9th 2022. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

How do I buy shares of Ainos?

Shares of AIMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Ainos own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Ainos investors own include CRISPR Therapeutics (CRSP), Iovance Biotherapeutics (IOVA), Vistagen Therapeutics (VTGN), Alpha Lithium (APHLF), Baidu (BIDU), DiDi Global (DIDIY) and Kingsoft Cloud (KC).

Company Calendar

• Last Earnings: 8/05/2024
• Today: 10/29/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:AIMD
• CUSIP: N/A
• CIK: 1014763
• Web: www.amarbio.com
• Phone: (858) 869-2986
• Fax: 806-376-9301
• Employees: 40
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($2.55)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-14,010,000.00
• Net Margins: -515.80%
• Pretax Margin: -515.76%
• Return on Equity: -44.32%
• Return on Assets: -40.35%

Debt

• Debt-to-Equity Ratio: 0.08
• Current Ratio: 1.92
• Quick Ratio: 1.45

Sales & Book Value

• Annual Sales: $65,122.00
• Price / Sales: 50.41
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.50 per share
• Price / Book: 0.34

Miscellaneous

• Outstanding Shares: 6,503,000
• Free Float: 13,322,000
• Market Cap: $3.28 million
• Optionable: Not Optionable
• Beta: 1.40